| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |